Stock Taper 
DOUBLELINE ETF ADVISER LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Agilent Technologies, Inc. | A | 3.1K | $411.51K |
 Zimmer Biomet Holdings, Inc. | ZBH | 2.98K | $256.72K |
 Vertex Pharmaceuticals Incorporated | VRTX | 2.95K | $1.46M |
 Cardinal Health, Inc. | CAH | 2.91K | $691.06K |
 Essex Property Trust, Inc. | ESS | 2.85K | $829.87K |
 Equinix, Inc. | EQIX | 2.73K | $2.85M |
 Elevance Health Inc. | ELV | 2.58K | $997.38K |
 Cencora, Inc. | COR | 2.37K | $670.95K |
 EastGroup Properties, Inc. | EGP | 2.34K | $474.32K |
 Jones Lang LaSalle Incorporated | JLL | 2.33K | $720.94K |
 IQVIA Holdings Inc. | IQV | 2.27K | $438.22K |
 Biogen Inc. | BIIB | 1.95K | $420.67K |
 HCA Healthcare, Inc. | HCA | 1.89K | $736.89K |
 Incyte Corporation | INCY | 1.82K | $206.54K |
 Veeva Systems Inc. | VEEV | 1.66K | $294.42K |
 ResMed Inc. | RMD | 1.57K | $306.16K |
 Quest Diagnostics Incorporated | DGX | 1.54K | $327.46K |
 Humana Inc. | HUM | 1.54K | $613.31K |
 McKesson Corporation | MCK | 1.43K | $1.08M |
 Regeneron Pharmaceuticals, Inc. | REGN | 1.21K | $753.86K |